Show simple item record

dc.contributor.authorSankey, Peter
dc.date.accessioned2021-04-20T11:46:14Z
dc.date.available2021-04-20T11:46:14Z
dc.date.issued2021-02
dc.identifier.citationHenderson D et al. Republished: Immune checkpoint inhibitor induced large vessel vasculitis. Drug Ther Bull. 2021 Feb;59(2):29-31. doi: 10.1136/dtb.2020.233496rep. Epub 2020 Oct 22.en_US
dc.identifier.pmid33093074
dc.identifier.doi10.1136/dtb.2020.233496rep
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621710
dc.language.isoenen_US
dc.publisherHighWireen_US
dc.relation.urlhttps://dtb.bmj.com/lookup/pmidlookup?view=long&pmid=33093074en_US
dc.rights© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.en_US
dc.subjectcancer interventionen_US
dc.subjectimmunologyen_US
dc.subjectprostate canceren_US
dc.subjectunwanted effects / adverse reactionsen_US
dc.subjectvasculitisen_US
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.en_US
dc.titleRepublished: Immune checkpoint inhibitor induced large vessel vasculitisen_US
dc.typeCase Reporten_US
dc.identifier.journalDrug and Therapeutics Bulletinen_US
dc.description.noteThis article is available to RD&E staff via NHS OpenAthens (subject to any publisher embargo). Click on the Publisher URL, and log in with NHS OpenAthens if prompted.en_US
dc.type.versionPublisheden_US
dc.description.admin-notepublished version, accepted version, submitted versionen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record